Positive phase I/IIa data reported for NCX-4016 in symptomatic peripheral arterial disease April 17, 2002
AVP antagonists, their SAR and biological activity described by R.W. Johnson at ACS meeting April 16, 2002
Enrollment complete in second phase II trial of pexelizumab in acute myocardial infarction April 11, 2002
Restoration of impaired angiogenesis in aging hearts with PDGF-AB provides cardioprotection April 8, 2002
RSS